单克隆B淋巴细胞增多症

魏冲; 张薇; 周道斌

doi:10.13201/j.issn.1004-2806.2021.09.015

单克隆B淋巴细胞增多症

- 中国医学科学院北京协和医学院北京协和医院血液科(北京, 100730)

详细信息

通讯作者: 周道斌,E-mail:zhoudb@pumch.cn

中图分类号: R733.72

收稿日期: 2020-08-27

Monoclonal B-cell lymphocytosis

More Information

Corresponding author: ZHOU Daobin, E-mail: zhoudb@pumch.cn

Received Date: 27 August 2020

摘要

- 单克隆B淋巴细胞增多症 /
- 慢性淋巴细胞白血病 /
- 分子遗传机制 /
- 免疫表型
- monoclonal B-cell lymphocytosis /
- chronic lymphocytic leukemia /
- molecular genetics /
- immuno-phenotype

HTML全文

参考文献(35)

[1]	Vogt RF,Shim YK,Middleton DC,et al.Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies[J].Br J Haematol,2007,139(5):690-700.
[2]	Rawstron AC,Green MJ,Kuzmicki A,et al.Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts[J].Blood,2002,100(2):635-639.
[3]	de Tute R,Yuille M,Catovsky D,et al.Monoclonal B-cell lymphocytosis(MBL)in CLL families:substantial increase in relative risk for young adults[J].Leukemia,2006,20(4):728-729.
[4]	Dagklis A,Fazi C,Sala C,et al.The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia(CLL)-like monoclonal B lymphocytosis is different from CLL:diagnostic implications for clinical monitoring[J].Blood,2009,114(1):26-32.
[5]	Nieto WG,Almeida J,Romero A,et al.Increased frequency(12%)of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach[J].Blood,2009,114(1):33-37.
[6]	Marti GE,Rawstron AC,Ghia P,et al.Diagnostic criteria for monoclonal B-cell lymphocytosis[J].Br J Haematol,2005,130(3):325-332.
[7]	Hallek M,Cheson BD,Catovsky D,et al.Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines[J].Blood,2008,111(12):5446-5456.Erratum in:Blood.2008 Dec 15;112(13):5259.
[8]	中华医学会血液学分会白血病淋巴瘤血组,中国抗癌协会血液肿瘤专业委员会,中国慢性淋巴细胞白血病工作组.中国慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的诊断和治疗指南(2018年版)[J].中华血液学杂志,2018,39(5):353-358.
[9]	Swerdlow SH,Campo E,Harris NL,et al.WHO classification of tumours of haematopoietic and lymphoid tissues[M].Lyon,France:IARC Press,2017:220-221.
[10]	Shim YK,Rachel JM,Ghia P,et al.Monoclonal B-cell lymphocytosis in healthy blood donors:an unexpectedly common finding[J].Blood,2014,123(9):1319-1326.
[11]	Goldin LR,Lanasa MC,Slager SL,et al.Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families[J].Br J Haematol,2010,151(2):152-158.
[12]	Mittal S,Blaylock MG,Culligan DJ,et al.A high rate of CLL phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura[J].Haematologica,2008,93(1):151-152.
[13]	Yang CL,Shen K,Xie QB,et al.Monoclonal B-cell Lymphocytosis in a Patient with Wegener Granulomatosis:A Case Report and Update on 2016 World Health Organization Classification[J].Chin Med J(Engl),2016,129(18):2258-2259.
[14]	Bruzzese V,Marrese C,Hassan C,et al.Prompt efficacy of very low-dose rituximab on monoclonal B lymphocytosis in a rheumatoid arthritis patient[J].Int J Rheum Dis,2013,16(6):764-765.
[15]	Rawstron AC,Shanafelt T,Lanasa MC,et al.Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis(MBL)[J].Cytometry B Clin Cytom,2010,78 Suppl 1(Suppl 1):S19-S23.
[16]	Swerdlow SH,Campo E,Pileri SA,et al.The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J].Blood,2016,127(20):2375-2390.
[17]	Criado I,Rodríguez-Caballero A,Gutiérrez ML,et al.Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome[J].Haematologica,2018,103(7):1198-1208.
[18]	Fazi C,Dagklis A,Cottini F,et al.Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals[J].Cytometry B Clin Cytom,2010,78 Suppl 1:S61-S68.
[19]	Vardi A,Dagklis A,Scarfò L,et al.Immunogenetics shows that not all MBL are equal:the larger the clone,the more similar to CLL[J].Blood,2013,121(22):4521-4528.
[20]	Strati P,Shanafelt TD.Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia:diagnosis,natural history,and risk stratification[J].Blood,2015,126(4):454-462.
[21]	Landgren O,Albitar M,Ma W,et al.B-cell clones as early markers for chronic lymphocytic leukemia[J].N Engl J Med,2009,360(7):659-667.
[22]	Kostopoulos IV,Paterakis G,Pavlidis D,et al.Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis[J].Blood Cancer J,2017,7(8):e597.
[23]	Rossi D,Sozzi E,Puma A,et al.The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors[J].Br J Haematol,2009,146(1):64-75.
[24]	Hallek M,Cheson BD,Catovsky D,et al.iwCLL guidelines for diagnosis,indications for treatment,response assessment,and supportive management of CLL[J].Blood,2018,131(25):2745-2760.
[25]	Döhner H,Stilgenbauer S,Benner A,et al.Genomic aberrations and survival in chronic lymphocytic leukemia[J].N Engl J Med,2000,343(26):1910-1916.
[26]	Baliakas P,Jeromin S,Iskas M,et al.Cytogenetic complexity in chronic lymphocytic leukemia:definitions,associations,and clinical impact[J].Blood,2019,133(11):1205-1216.
[27]	Xia Y,Fan L,Wang L,et al.Frequencies of SF3B1,NOTCH1,MYD88,BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia:disparities with Europeans[J].Oncotarget,2015,6(7):5426-5434.
[28]	Barrio S,Shanafelt TD,Ojha J,et al.Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome[J].Leukemia,2017,31(1):170-176.
[29]	Karube K,Scarfò L,Campo E,et al.Monoclonal B cell lymphocytosis and "in situ" lymphoma[J].Semin Cancer Biol,2014,24:3-14.
[30]	Berger F,Felman P,Thieblemont C,et al.Non-MALT marginal zone B-cell lymphomas:a description of clinical presentation and outcome in 124 patients[J].Blood,2000,95(6):1950-1956.
[31]	Xochelli A,Kalpadakis C,Gardiner A,et al.Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin:is this a distinct entity?[J].Blood,2014,123(8):1199-1206.
[32]	Xochelli A,Oscier D,Stamatopoulos K.Clonal B-cell lymphocytosis of marginal zone origin[J].Best Pract Res Clin Haematol,2017,30(1-2):77-83.
[33]	Maitre E,Troussard X.Monoclonal B-cell lymphocytosis[J].Best Pract Res Clin Haematol,2019,32(3):229-238.
[34]	Solomon BM,Chaffee KG,Moreira J,et al.Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis[J].Leukemia,2016,30(2):331-336.
[35]	Moreira J,Rabe KG,Cerhan JR,et al.Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis(MBL):a cohort study of newly diagnosed cases compared to controls[J].Leukemia,2013,27(1):136-141.